Ronald A Reilkoff – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailrreilkofumnedu

Research activity per year

4 Active
5 Finished

4 results

Filter

Active
A Phase 2, Single-Arm, Open-Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of INBRX-101 in Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysema
Reilkoff, R. A. (PI)
INHIBRX, INC.
5/1/24 → 5/31/28
Project: Research project
A Phase 2, Double-Blind, Randomized, Active-Control, Parallel Group Study to Assessthe Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of INBRX-101 Compared to Plasma Derived Alpha1-Proteinase Inhibitor (A1PI) Augmentation Therapy in Adul
Reilkoff, R. A. (PI)
INHIBRX, INC.
9/1/23 → 9/1/26
Project: Research project
Assessment of Implementation Methods in Sepsis and Respiratory Failure (AIMS) Study
Reilkoff, R. A. (PI)
SOCIETY OF CRITICAL CARE MEDICINE, NIH NAT'L HEART, LUNG, AND BLOOD INSTITU
9/1/22 → 6/30/26
Project: Research project
A Multicenter, Randomized, Open-label, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of Prolastin®-C Liquid plus Standard Medical Treatment (SMT) versus SMT alone in Hospitalized Subjects with COVID-19
Reilkoff, R. A. (PI)
GRIFOLS THERAPEUTICS, INC
2/1/21 → 2/28/26
Project: Research project